Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Milsom

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Gene Medicine|February 24, 2004
Protection and selection for gene therapy in the hematopoietic systemMichael D Milsom, Leslie J Fairbairn
EMBO Molecular Medicine|August 3, 2010
Gaining the hard yard: pre-clinical evaluation of lentiviral-mediated gene therapy for the treatment of beta-thalassemiaMichael D Milsom, David A Williams
DNA Repair|May 8, 2007
Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotectionMichael D Milsom, David A Williams
Cells & Development|April 26, 2023
Recent advances in understanding the impact of infection and inflammation on hematopoietic stem and progenitor cellsMichael D Milsom, Marieke A G Essers
Cell Stem Cell|May 5, 2018
Causes and Consequences of Hematopoietic Stem Cell HeterogeneitySimon Haas, Andreas Trumpp, Michael D Milsom
Seminars in Cancer Biology|October 2, 2017
Impact of DNA methylation programming on normal and pre-leukemic hematopoiesisJens Langstein, Michael D Milsom, Daniel B Lipka
Anemia|June 8, 2012
Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic StrategiesAnja Geiselhart, Amelie Lier, Dagmar Walter, et al.
Experimental Hematology|December 26, 2024
Reconsidering the usual suspects in age-related hematologic disorders: is stem cell dysfunction a root cause of aging?Foteini Fotopoulou, Esther Rodríguez-Correa, Charles Dussiau, et al.
Haematologica|June 4, 2009
Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766Michael D Milsom, Andrew W Lee, Yi Zheng, et al.
Cell Cycle (Georgetown, Tex.)|July 17, 2015
The Fanconi anemia pathway is required for efficient repair of stress-induced DNA damage in haematopoietic stem cellsPaul Kaschutnig, Ruzhica Bogeska, Dagmar Walter, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Gene Medicine|February 24, 2004
Protection and selection for gene therapy in the hematopoietic systemMichael D Milsom, Leslie J Fairbairn
EMBO Molecular Medicine|August 3, 2010
Gaining the hard yard: pre-clinical evaluation of lentiviral-mediated gene therapy for the treatment of beta-thalassemiaMichael D Milsom, David A Williams
DNA Repair|May 8, 2007
Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotectionMichael D Milsom, David A Williams
Cells & Development|April 26, 2023
Recent advances in understanding the impact of infection and inflammation on hematopoietic stem and progenitor cellsMichael D Milsom, Marieke A G Essers
Cell Stem Cell|May 5, 2018
Causes and Consequences of Hematopoietic Stem Cell HeterogeneitySimon Haas, Andreas Trumpp, Michael D Milsom
Seminars in Cancer Biology|October 2, 2017
Impact of DNA methylation programming on normal and pre-leukemic hematopoiesisJens Langstein, Michael D Milsom, Daniel B Lipka
Anemia|June 8, 2012
Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic StrategiesAnja Geiselhart, Amelie Lier, Dagmar Walter, et al.
Experimental Hematology|December 26, 2024
Reconsidering the usual suspects in age-related hematologic disorders: is stem cell dysfunction a root cause of aging?Foteini Fotopoulou, Esther Rodríguez-Correa, Charles Dussiau, et al.
Haematologica|June 4, 2009
Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766Michael D Milsom, Andrew W Lee, Yi Zheng, et al.
Cell Cycle (Georgetown, Tex.)|July 17, 2015
The Fanconi anemia pathway is required for efficient repair of stress-induced DNA damage in haematopoietic stem cellsPaul Kaschutnig, Ruzhica Bogeska, Dagmar Walter, et al.
Pageof 8